Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Cefoxitin, cefotetan, and other cephamycins

Simple item page
dc.contributor.authorDaveson, Kathryn
dc.contributor.editorGrayson, M L
dc.contributor.editorCosgrove, S E
dc.contributor.editorCrowe, S
dc.contributor.editorHope, W
dc.contributor.editorMcCa, J S
dc.date.accessioned2024-03-12T22:03:32Z
dc.date.issued2017
dc.date.updated2022-10-23T07:16:12Z
dc.description.abstractThe cephamycins are often referred to as second-generation cephalosporin antibiotics, although they differ quite markedly from antibiotics such as cefuroxime or cefaclor. A primary attribute of the cephamycins is their resistance to a variety of beta-lactamase types, such as the extended-spectrum betalactamase (ESBLs) and their narrower-spectrum parents, TEM and SHV beta-lactamases. The cephamycins to be discussed in this chapter are cefotetan and cefoxitin primarily, with secondary discussion of cefmetazole and flomoxef.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.isbn9781315152110en_AU
dc.identifier.urihttp://hdl.handle.net/1885/315939
dc.language.isoen_AUen_AU
dc.publisherCRC Press - Taylor & Francis Groupen_AU
dc.relation.ispartofKucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugsen_AU
dc.relation.isversionof7th Edition
dc.rights© 2017 The authorsen_AU
dc.titleCefoxitin, cefotetan, and other cephamycinsen_AU
dc.typeBook chapteren_AU
local.bibliographicCitation.lastpage414en_AU
local.bibliographicCitation.placeofpublicationUnited States
local.bibliographicCitation.startpage403en_AU
local.contributor.affiliationDaveson, Kathryn, College of Health and Medicine, ANUen_AU
local.contributor.authoruidDaveson, Kathryn, u1002447en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor321402 - Clinical pharmacology and therapeuticsen_AU
local.identifier.ariespublicationa383154xPUB28835en_AU
local.identifier.doi10.1201/9781315152110en_AU
local.identifier.scopusID2-s2.0-85056680047
local.publisher.urlhttps://taylorandfrancis.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
TMP94993846202431385353.pdf
Size:
548.89 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS